Cel
The overarching aims of the DIRECT consortium, consisting of 20 leading academic groups in diabetes and 5 EFPIA companies, are to identify biomarkers that address current bottlenecks in diabetes drug development and to develop a stratified medicines approach to treatment of type 2 diabetes with either existing or novel therapies.
There is heterogeneity in who develops diabetes, the rate at which their subsequent diabetes progresses, how they respond to diabetes therapy and who develops micro- and macrovascular complications. In the DIRECT consortium we propose to identify biomarkers to identify subtypes with rapid diabetes development and progression and altered response to diabetes treatments, and develop and use these biomarkers in clinical trials.
Two phenotyping work packages will focus on glycaemic deterioration and therapeutic response. For each, the DIRECT consortium brings considerable existing resource, which will be augmented by large-scale prospective cohort collection with intensive physiological and imaging phenotyping. Additional data will be added, such as existing studies on acute response to intravenous beta-cell secretagogues, and functional genomics on human islets, liver, muscle and adipose tissue, to maximise the power and utility of an innovative integrated biology approach. To enable computational multi-level integration across phenotypes and data types, a robust and secure data repository will be developed with strict data governance. As the ultimate aim of DIRECT is patient stratification, biomarkers arising from the discovery work will be used to design one or more prospective clinical trials. These will validate the biomarker(s) of interest, and establish utility in clinical practice and/or trial design and drug development. As a result, this consortium offers considerable potential to achieve major progress towards a personalized medicines approach to the treatment of type 2 diabetes.
Dziedzina nauki
Zaproszenie do składania wniosków
IMI-JU-03-2010
Zobacz inne projekty w ramach tego zaproszenia
System finansowania
JTI-CP-IMI - Joint Technology Initiatives - Collaborative Project (IMI)Koordynator
65929 Frankfurt Am Main
Niemcy
Zobacz na mapie
Uczestnicy (25)
DD1 4HN Dundee
Zobacz na mapie
BA2 7AY Bath
Zobacz na mapie
00185 Roma
Zobacz na mapie
2800 Kongens Lyngby
Zobacz na mapie
72074 Tuebingen
Zobacz na mapie
85764 Neuherberg
Zobacz na mapie
08036 Barcelona
Zobacz na mapie
SW7 2AZ LONDON
Zobacz na mapie
100 44 Stockholm
Zobacz na mapie
75794 Paris
Zobacz na mapie
2333 ZA Leiden
Zobacz na mapie
1165 Kobenhavn
Zobacz na mapie
70211 KUOPIO
Zobacz na mapie
22100 Lund
Zobacz na mapie
NE1 7RU Newcastle Upon Tyne
Zobacz na mapie
EX4 4QJ Exeter
Zobacz na mapie
1211 Geneve
Zobacz na mapie
OX1 2JD Oxford
Zobacz na mapie
89081 Ulm
Zobacz na mapie
1081 HV Amsterdam
Zobacz na mapie
2880 Bagsvaerd
Zobacz na mapie
RG21 4FA Basingstoke
Zobacz na mapie
92284 Courbevoie
Zobacz na mapie
59037 Lille
Zobacz na mapie
55218 Ingelheim
Zobacz na mapie